Trial Outcomes & Findings for Spinal Cord Stimulation (SCS) Dosing Study (NCT NCT03284411)

NCT ID: NCT03284411

Last Updated: 2020-04-15

Results Overview

To characterize the effect of four different amplitude settings on baseline SCS therapy satisfaction. At each follow-up visit, the following question was asked to measure satisfaction: "Overall how satisfied or unsatisfied are you with this therapy?". The response choices were as follows: "very satisfied", "somewhat satisfied", "neutral", "somewhat unsatisfied", "very unsatisfied". Each subject was considered to have maintained their baseline SCS therapy satisfaction if they selected the response "very satisfied", "somewhat satisfied", or "neutral", otherwise they were considered dissatisfied with the therapy. The first visit in which each subject reported dissatisfaction of the therapy was recorded. The amplitude used during the prior visit was then considered to be the minimum amplitude that maintained each subject's therapy satisfaction. The frequency and percentage of subjects' that maintained baseline satisfaction were reported at each amplitude level.

Recruitment status

COMPLETED

Study phase

PHASE4

Target enrollment

30 participants

Primary outcome timeframe

8 weeks

Results posted on

2020-04-15

Participant Flow

Participant milestones

Participant milestones
Measure
Spinal Cord Stimulation
Each subject was programmed to 4 different amplitude settings (80, 60, 40, and 20 percent of their perception threshold amplitude). Spinal Cord Stimulation: Programming
Overall Study
STARTED
30
Overall Study
COMPLETED
30
Overall Study
NOT COMPLETED
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Spinal Cord Stimulation (SCS) Dosing Study

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Spinal Cord Stimulation
n=30 Participants
Each subject was programmed to 4 different amplitude settings (80, 60, 40, and 20 percent of their perception threshold). Spinal Cord Stimulation: Programming
Age, Continuous
65.1 years
STANDARD_DEVIATION 11.9 • n=5 Participants
Sex: Female, Male
Female
23 Participants
n=5 Participants
Sex: Female, Male
Male
7 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
0 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
0 Participants
n=5 Participants
Race (NIH/OMB)
White
30 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
Region of Enrollment
United States
30 participants
n=5 Participants

PRIMARY outcome

Timeframe: 8 weeks

To characterize the effect of four different amplitude settings on baseline SCS therapy satisfaction. At each follow-up visit, the following question was asked to measure satisfaction: "Overall how satisfied or unsatisfied are you with this therapy?". The response choices were as follows: "very satisfied", "somewhat satisfied", "neutral", "somewhat unsatisfied", "very unsatisfied". Each subject was considered to have maintained their baseline SCS therapy satisfaction if they selected the response "very satisfied", "somewhat satisfied", or "neutral", otherwise they were considered dissatisfied with the therapy. The first visit in which each subject reported dissatisfaction of the therapy was recorded. The amplitude used during the prior visit was then considered to be the minimum amplitude that maintained each subject's therapy satisfaction. The frequency and percentage of subjects' that maintained baseline satisfaction were reported at each amplitude level.

Outcome measures

Outcome measures
Measure
Spinal Cord Stimulation
n=30 Participants
Each subject was programmed to 4 different amplitude settings (80, 60, 40, and 20 percent of perception threshold). Spinal Cord Stimulation: Programming
SCS Therapy Satisfaction
80% perception threshold
2 Participants
SCS Therapy Satisfaction
Baseline
6 Participants
SCS Therapy Satisfaction
60% perception threshold
1 Participants
SCS Therapy Satisfaction
40% perception threshold
0 Participants
SCS Therapy Satisfaction
20% perception threshold
21 Participants

SECONDARY outcome

Timeframe: 8 weeks

To characterize the effect of four different amplitude settings on baseline pain relief. During each follow-up period the VAS pain score was recorded once a day, on a multi-day diary, where subjects rated their pain by making a vertical slash mark through the 0-10 cm line that best described their pain during the last 24 hours, with 0 = No pain and 10 = Worst pain imaginable. The higher VAS pain score represented worse pain. The average VAS pain scores from the last 3 days of the diary prior to the scheduled visit was used for analysis. Each subject was considered to have maintained their baseline pain if there was less than a 2 point increase in their average pain score at the follow-up period. The amplitude used during the prior visit was then considered to be the minimum amplitude that maintained the subject's pain relief. The frequency and percentage of subjects' that maintained their average baseline VAS pain score were reported at each amplitude level.

Outcome measures

Outcome measures
Measure
Spinal Cord Stimulation
n=30 Participants
Each subject was programmed to 4 different amplitude settings (80, 60, 40, and 20 percent of perception threshold). Spinal Cord Stimulation: Programming
Number of Participants Maintaining Baseline Pain as Measured on the Visual Analog Scale (VAS)
Baseline
5 Participants
Number of Participants Maintaining Baseline Pain as Measured on the Visual Analog Scale (VAS)
80% perception threshold
3 Participants
Number of Participants Maintaining Baseline Pain as Measured on the Visual Analog Scale (VAS)
60% perception threshold
1 Participants
Number of Participants Maintaining Baseline Pain as Measured on the Visual Analog Scale (VAS)
40% perception threshold
2 Participants
Number of Participants Maintaining Baseline Pain as Measured on the Visual Analog Scale (VAS)
20% perception threshold
19 Participants

Adverse Events

Spinal Cord Stimulation

Serious events: 0 serious events
Other events: 5 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
Spinal Cord Stimulation
n=30 participants at risk
Each subject was programmed to 4 different amplitude settings (80, 60, 40, and 20 percent of their perception threshold) Spinal Cord Stimulation: Programming
Product Issues
Device stimulation issue
10.0%
3/30 • Number of events 3 • Adverse events were collected from enrollment to study discontinuation with an average of 2.2 months
General disorders
Inadequate analgesia
3.3%
1/30 • Number of events 1 • Adverse events were collected from enrollment to study discontinuation with an average of 2.2 months
Musculoskeletal and connective tissue disorders
Back pain
3.3%
1/30 • Number of events 1 • Adverse events were collected from enrollment to study discontinuation with an average of 2.2 months

Additional Information

SCS Dosing Clinical Research Study Team

Medtronic

Phone: 800-633-8766

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place